BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6290921)

  • 1. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.
    Buckingham JC
    Neuroendocrinology; 1982; 35(2):111-6. PubMed ID: 6290921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin.
    Buckingham JC
    Neuroendocrinology; 1986; 42(2):148-52. PubMed ID: 2936971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat.
    Buckingham JC
    Eur J Pharmacol; 1984 Feb; 98(2):211-21. PubMed ID: 6325216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships of opioidergic and adrenergic mechanisms controlling the secretion of corticotrophin releasing factor in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1987 Sep; 46(3):199-206. PubMed ID: 2821423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat.
    el Daly ES
    Life Sci; 1996; 59(22):1881-90. PubMed ID: 8950285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamo-pituitary-interrenal responses to opioid substances in the trout. I. Effects of morphine on the release in vitro of corticotrophin-releasing activity from the hypothalamus and corticotrophin from the pituitary gland.
    Bird DJ; Buckingham JC; Baker BI; Mukherjee S
    Gen Comp Endocrinol; 1987 Oct; 68(1):33-9. PubMed ID: 2822526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
    Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P
    Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats.
    Suemaru S; Hashimoto K; Ota Z
    Acta Med Okayama; 1985 Dec; 39(6):463-70. PubMed ID: 3004111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of dynamics of corticotropin-releasing factor (CRF) activity in the rat hypothalamus under stress].
    Fujieda K
    Hokkaido Igaku Zasshi; 1976 May; 51(3):199-216. PubMed ID: 184025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity.
    Suemaru S; Hashimoto K; Ota Z
    Endocrinol Jpn; 1986 Aug; 33(4):441-8. PubMed ID: 3024953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus.
    Walker CD; Perrin M; Vale W; Rivier C
    Endocrinology; 1986 Apr; 118(4):1445-51. PubMed ID: 3004915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat.
    Cover PO; Buckingham JC
    J Endocrinol; 1989 May; 121(2):213-20. PubMed ID: 2547002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 44(1):36-40. PubMed ID: 3024056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.